| [1] |
Gammoh N, Wilkinson S. Autophagy in cancer biology and therpy[J]. Front Biol, 2014, 9(1):35-50.
|
| [2] |
Felley-Bosco E, Stahel RA. Chemotherapy of malignant pleural mesothelioma induces both senescence and apoptosis[M]//Hayat MA. Tumor Dormancy, Quiescence, and Senescence, Springer, 2013: 261-268.
|
| [3] |
Rohatgi RA, Shaw LM. An autophagy-independent function of Beclin 1 in cancer[J]. Mol Cell Oncol, 2016, 3(1):e1030539.
|
| [4] |
Toton E, Lisiak N, Sawicka P, et al. Beclin-1 and its role as a target for anticancer therapy[J]. J Physiol Pharmacol, 2014, 65(4):459-467.
|
| [5] |
Fu LL, Cheng Y, Liu B. Beclin-1: autophagic regulator and therapeutic target in cancer[J]. Int J Biochem Cell Biol, 2013, 45(5):921-924.
|
| [6] |
Karantza-Wadsworth V, White E. Role of autophagy in breast cancer[J]. Autophagy, 2007, 3(6):610-613.
|
| [7] |
Huang R, Liu W. Identifying an essential role of nuclear LC3 for autophagy[J]. Autophagy, 2015, 11(5):852-853.
|
| [8] |
Li JP, Yang YX, Liu QL, et al. The investigational Aurora kinase A inhibitor alisertib(MLN8237) induces cell cycle G2/M arrest,apoptosis,and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells[J]. Drug Design, Development and Therapy, 2015, 9:1627-1652.
|
| [9] |
Weh KM, Howell AB, Kresty LA.. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma[J]. Mol Carcinog, 2016, 55(11):1876-1885.
|
| [10] |
Valente G, Morani F, Nicotra G, et al. Expression and clinical significance of the autophagy proteins Beclin 1 and LC3 in ovarian cancer[J]. Biomed Res Int, 2014, 2014:462658.
|
| [11] |
Hu YF, Lei X, Zhang HY, et al. Expressions and clinical significance of autophagy-related markers Beclin1, LC3, and EGFR in human cervical squamous cell carcinoma[J]. Onco Targets Ther, 2015, 8:2243-2249.
|
| [12] |
Spolverato G, Pucciarelli S, Bertorelle R, et al. Predictive factors of the response of rectal cancer to neoadjuvant radiochemotherapy[J].Cancers (Basel), 2011, 3(2):2176-2194.
|
| [13] |
Hur H, Kim NK, Min BS, et al. Can a biomarkerbased scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?[J]. Dis Colon Rectum, 2014, 57(5):592-601.
|
| [14] |
高可娃. Beclin-1和LC3在乳腺癌中表达及其化疗前后的变化[D].湖南：中南大学，2014.
|
| [15] |
李俊，刘晓渝，江歌丽, 等. 自噬相关基因在乳腺癌ET方案新辅助化疗疗效预测中的作用[J]. 重庆医学, 2015, 44(3):337-342.
|
| [16] |
李静. Beclin-1、Caspase3在宫颈鳞癌患者新辅助化疗前后癌组织中的表达及其意义[D]. 河南: 郑州大学, 2010.
|
| [17] |
王晓云，张凡，陈江平, 等. 自噬活性相关蛋白Cathepsin-D、LC3表达与宫颈鳞状细胞癌新辅助化疗耐药关系的研究[J]. 中国妇幼保健, 2012, 27(4):609-611.
|
| [18] |
Dattani M, Moran BJ. Watch and wait after neoadjuvant therapy for rectal cancer[J]. Br J Surg, 2016, 103(6):629-631.
|
| [19] |
Guo GF, Jiang WQ, Zhang B, et al. Autophagyrelated proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer[J]. World J Gastroenterol, 2011,17(43):4779-4786.
|
| [20] |
Shim BY, Sun DS, Won HS, et al. Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy[J]. BMC Cancer, 2016, 16:207.
|
| [21] |
Hu YL, Jahangiri A, Delay M, et al. Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy[J]. Cancer Res, 2012, 72(17):4294-4299.
|
| [22] |
Schonewolf CA, Mehta M, Schiff D, et al. Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation[J]. World J Gastrointest Oncol, 2014, 6(3):74-82.
|
| [23] |
Lei YY, Zhang D, Yu J, et al. Targeting autophagy in cancer stem cell as an anticancer therapy[J]. Cancer Letters, 2017, 393:33-39.
|
| [24] |
Sui X, Jin L, Huang X, et al. p53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment[J]. Autophagy, 2011, 7(6):565-571.
|
| [25] |
Morselli E, Shen S, Ruckenstuhl C, et al. p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200[J]. Cell Cycle, 2011, 10(16):2763-2769.
|
| [26] |
Paillas S, Causse A, Marzi L, et al. MAPK14/p38alpha confers irinotecan resistance to TP53-defective cells by inducing survival autophagy[J]. Autophagy, 2012, 8(7):1098-1112.
|
| [27] |
Tougeron D, Park JM, Okamoto K, et al. Use of the essential autophagy protein beclin 1 to regulate DNA damage response and predict response to chemoradiation in rectal cancer[J]. J Clin Oncol, 2014, 32(3):2318.
|
| [28] |
Liang X, Tang JC, Lian YL, et al. Suppression of autophagy by chloroquine sensitizes 5-fluorouracil-mediated cell death in gallbladder carcinoma cells[J]. Cell Biosci, 2014, 4(1):10.
|
| [29] |
陈盛. 乳腺癌新辅助化疗后残留肿瘤自噬及其与患者预后的相关性[D]. 上海: 复旦大学, 2012.
|
| [30] |
Li J, Yang B, Zhou Q, et al. Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition[J]. Carcinogeneis, 2013, 34(6):1343-1351.
|
| [31] |
Chen Z, Li Y, Zang C, et al. Downregulation of Beclin1 and impairment of autophagy in a small population of colorectal cancer[J]. Dig Dis Sci, 2013, 58(10):2887-2894.
|